RA Capital Management - SILVERBACK THERAPEUTICS INC ownership

Quarter-by-quarter ownership
RA Capital Management ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$35,757,583
+77.3%
9,459,678
+214.3%
0.70%
+84.8%
Q2 2023$20,164,843
+2.9%
3,009,6780.0%0.38%
-14.2%
Q1 2023$19,593,004
-23.7%
3,009,6780.0%0.44%
-14.8%
Q4 2022$25,672,553
+121.3%
3,009,678
+72.8%
0.52%
+154.1%
Q4 2021$11,603,000
-33.3%
1,742,1860.0%0.20%
-14.9%
Q3 2021$17,387,000
-67.7%
1,742,1860.0%0.24%
-72.1%
Q2 2021$53,816,000
-29.2%
1,742,1860.0%0.86%
-24.6%
Q1 2021$76,012,000
-5.8%
1,742,1860.0%1.15%
+1.5%
Q4 2020$80,733,0001,742,1861.13%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$10,085,0003.26%
K2 PRINCIPAL FUND, L.P. 3,247,533$16,890,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,045,234$5,519,0001.09%
Orbimed Advisors 8,740,887$46,152,0000.86%
Rubric Capital Management LP 2,695,170$14,230,0000.72%
Prosight Management, LP 196,257$1,036,0000.56%
Nantahala Capital Management 1,249,863$6,599,0000.43%
Oasis Management Co Ltd. 317,662$1,677,0000.28%
TANG CAPITAL MANAGEMENT LLC 409,463$2,162,0000.26%
APOGEM CAPITAL LLC 13,793$73,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders